Answer Happy

You have recently joined Clover Biotech Inc. who has been contracted to produce plant-derived therapeutic proteins targeted at the Zika. Clover Biotech Inc. has developed a cocktail of 3 antibodies (ZK1 to ZK3) that have been shown to be very effective during the early phases of infection when administered as a cocktail containing all 3 antibodies. Clover Biotech Inc. has patented the genetic sequences that encode the antibodies and the genes encoding these antibodies are in binary plasmids that are propagated in E. coli. Detail (1) the rapid and short- term and (2) long-term strategies you would adopt for the production of the antibodies in plants to deal with a possible pandemic.